Literature DB >> 7859783

Exaggerated role of prone technique in breast cancer imaging with technetium-99m methoxyisobutylisonitrile.

C Aktolun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7859783     DOI: 10.1007/bf00182366

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


× No keyword cloud information.
  6 in total

1.  Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201.

Authors:  C Aktolun; H Bayhan; M Kir
Journal:  Clin Nucl Med       Date:  1992-03       Impact factor: 7.794

2.  Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs.

Authors:  I M Hassan; A Sahweil; C Constantinides; A Mahmoud; M Nair; Y T Omar; H M Abdel-Dayem
Journal:  Clin Nucl Med       Date:  1989-05       Impact factor: 7.794

3.  A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer.

Authors:  V W Lee; E J Sax; D B McAneny; S Pollack; R A Blanchard; R M Beazley; M T Kavanah; R J Ward
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

4.  Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.

Authors:  B Caner; M Kitapçi; T Aras; G Erbengi; O Uğur; C Bekdik
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

5.  Breast carcinomas detected by thallium-201 scintigraphy.

Authors:  M Sluyser; C A Hoefnagel
Journal:  Cancer Lett       Date:  1988-06-15       Impact factor: 8.679

Review 6.  Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.

Authors:  I Khalkhali; I Mena; L Diggles
Journal:  Eur J Nucl Med       Date:  1994-04
  6 in total
  1 in total

Review 1.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.